Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clinesian was a boutique global contract research organization (CRO) established as a joint venture between ClinicAid Research Management and Quartesian. The firm specialized in providing end-to-end functional services for Phase I through Phase IV clinical trials, including project management, clinical monitoring, data management, biostatistics, and medical writing. With a geographic footprint spanning the United States, India, and Ukraine, Clinesian catered to the pharmaceutical, biotechnology, and medical device sectors. The company's operations were effectively absorbed or phased out following the acquisition of its partner Quartesian by Precision Medicine Group in 2021. Clinesian was known for its high-touch, customized approach to clinical research, leveraging technologies like Oracle Clinical to streamline trial operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clinesian.